We are building a strong, well-run business, structured to deliver sustainable results over the long term.
Along with biotechnology leadership, the ARIAD team is focused on its commitment
to deliver long-term value to investors through solid business execution. That means
maintaining disciplined cost control, thoughtful capital deployment and the highest
standards of corporate governance.
Webcast - Replay ARIAD Pharmaceuticals, Inc. at Goldman Sachs 36th Annual Global Healthcare Conference 06/10/15 at 11:20 a.m. PT
ARIAD Pharmaceuticals, Inc. at Goldman Sachs 36th Annual Global Healthcare Conference Wednesday, June 10, 2015 11:20 a.m. PT